Custom Manufacturing
Bespoke production with clinical-grade precision.
Built around the business reality of your team.
Generic manufacturing capacity is everywhere. Manufacturing that respects the molecule, the patient, and the regulator is rare. Our facilities are designed for the products that other CDMOs decline — complex APIs, sterile injectables, high-potency compounds, and cold-chain biologics.
Tech transfer failures, deviation rates, and supply interruptions cost the industry billions every year. We engineer those risks out from the first batch.
A method, not just a capability.
Quality-by-Design framework applied from tech transfer through commercial release.
Continuous process verification with real-time release testing.
Single-use systems and modular suites for rapid product changeover.
Integrated supply planning with dual-source raw materials.
Clear deliverables, audit-ready documentation.
API Manufacturing
Small molecules, high-potency APIs, and controlled substances at clinical and commercial scale.
Sterile Fill-Finish
Vials, prefilled syringes, and cartridges under EU GMP Annex 1 standards.
Solid & Liquid Dose
Tablets, capsules, sachets, oral suspensions, and topical formulations.
Packaging & Serialisation
DSCSA, EU FMD, and country-specific track-and-trace compliance.
The difference is in the discipline.
EU GMP & FDA
Inspected and approved by major regulatory authorities with a clean compliance record.
Tech Transfer Excellence
Dedicated transfer team minimises batch failures and accelerates time-to-supply.
Capacity When You Need It
Reserved capacity agreements protect your launch and resupply timelines.
Total Cost Transparency
No hidden change-order economics. You see the cost model from day one.
Need capacity, a tech transfer partner, or a CDMO who treats your product like their own?
Our team responds within one business day with a tailored capability brief and next-step proposal.
Brief our Custom Manufacturing team.
Submissions are reviewed by the capability lead within one business day. All information is treated as confidential under our standard Mutual NDA framework.
Capability lead acknowledges within 24 business hours with a reference number.
Mutual NDA executed prior to detailed technical exchange.
Scoping call with subject-matter experts and a written capability brief.